Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Oct 27, 2022; 14(10): 1907-1919
Published online Oct 27, 2022. doi: 10.4254/wjh.v14.i10.1907
Table 3 Comparison of patients with and without liver function test abnormalities
VariableAlanine aminotransferase level (n = 161)
P value
High (> 41 U/L), 14 (8.7)
Normal (≤ 41 U/L), 147 (91.3)
SexFemale9 (64.3)61(41.5)0.157a
Male5 (35.7)86 (58.5)
NationalityBahraini9 (64.3)104 (70.7)0.760a
Non-Bahraini5 (35.7)43 (29.3)
Gestational age (n = 135)Term8 (57.1)98 (66.7)0.683
Preterm1 (7.1)28 (19.0)
Age at presentation (mo), mean ± SD10.1 ± 12.810.6 ± 17.30.535b
Age at the time of study (mo), mean ± SD37.5 ± 13.237.8 ± 17.50.394b
Length of hospital stay (d), mean ± SD18.0 ± 19.313.4 ± 41.10.025b
History of fever9 (7.9)105 (92.1)0.552a
White blood cell count (× 109/L), mean ± SD12.2 ± 7.010.6 ± 5.30.764b
Hemoglobin (g/dL), mean ± SD11.6 ± 2.111.5 ± 2.40.796b
Platelet count (× 109/L), mean ± SD335.4 ± 194.8417.6 ± 178.50.109b
Total serum protein (g/L), mean ± SD56.6 ± 7.357.9 ± 8.90.895b
Serum globulin (g/L), mean ± SD16.71 ± 3.6918.1 ± 11.20.801b
Serum albumin (g/L), mean ± SD39.86 ± 5.8941.63 ± 11.10.971b
Total bilirubin (µmol/L), mean ± SD29.4 ± 41.238.11 ± 62.810.794b
Direct bilirubin (µmol/L), (n = 71), mean ± SD24.1 ± 39.910.5 ± 5.70.722b
Indirect bilirubin (µmol/L), (n = 71), mean ± SD22.5 ± 17.962.0 ± 75.10.184b
Alkaline phosphatase (U/L), mean ± SD271.9 ± 217.2239.9 ± 133.10.935b
Gamma-glutamyl transferase (U/L), (n = 145), mean ± SD92.4 ± 88.260.6 ± 79.00.080b
Prothrombin time, (n = 46), mean ± SD13.2 ± 1.613.8 ± 3.00.809b
INR, (n = 46), mean ± SD1.1 ± 0.11.2 ± 0.30.831b
PTT, (n = 46), mean ± SD25.5 ± 4.928.8 ± 10.40.579b
Fibrinogen, (n = 34), mean ± SD326.4 ± 387.2277.3 ± 166.40.581b
Thrombin time, (n = 33), mean ± SD21.4 ± 7.316.9 ± 2.00.131b
Random blood glucose, (n = 52), mean ± SD6.0 ± 1.06.0 ± 1.00.905b
Positive blood culture (n = 127)2 (14.3)10 (6.8)0.278a
Positive urine culture (n = 88)3 (21.4)4 (2.7)0.030a
Positive cerebrospinal fluid culture (n = 23)0 (0.0)1.0 (0.7)1.000a
Positive RSV test (n = 159)6 (42.9)46 (31.3)0.356a
Antibiotic use (n = 157)11 (78.6)115 (78.2)1.000a
Complications2 (14.3)28 (19)1.000a
Admission to the intensive care unit1 (7.1)10 (6.8)1.000a
Mortality1 (7.1)8 (5.4)0.569a